Online citations, reference lists, and bibliographies.
← Back to Search

Pharmacokinetic Interaction Of Ketoconazole And Itraconazole With Ciprofloxacin

H. Abou-Auda, A. Mustafa, M. Al-Humayyd
Published 2008 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The effect of the concomitant administration of the antifungal drugs ketoconazole (KTC) and itraconazole (ITC) on the pharmacokinetics of ciprofloxacin (CIP) following short‐ and long‐term administration in mice was investigated. Animals received either a dose of CIP (20 mg/kg, i.p.), CIP (20 mg/kg, i.p.) together with KTC (50 mg/kg, p.o.) or CIP (20 mg/kg, i.p.) and ITC (30 mg/kg, p.o.). The same treatments were repeated for 7 days. Blood samples were collected up to 4 h following drug administration and two urine samples were collected at 2 h and 4 h after drug administration. CIP plasma concentrations were significantly higher in KTC‐ and ITC‐treated groups compared with the corresponding control groups. The concomitant administration of KTC or ITC with CIP also significantly (p<0.05) increased Cmax, t1/2, MRT and AUC0−∞ with no change in Tmax. CIP clearance was significantly reduced by both agents. KTC and ITC reduced CIP urinary excretion. This study suggests that an important pharmacokinetic interaction between CIP and KTC or ITC is likely to occur when either of the two antifungal drugs is administered concomitantly with CIP. The results may suggest possible reductions in total clearance of CIP, owing to inhibition of its renal tubular excretion by KTC and ITC. Copyright © 2007 John Wiley & Sons, Ltd.
This paper references
10.7326/0003-4819-108-3-502_1
Drug facts and comparisons
Erwin K. Kastrup (1977)
10.1002/JPS.2600710332
Noncompartmental determination of the steady-state volume of distribution for any mode of administration.
D. Perrier (1982)
Ketoconazole labeling revised.
(1984)
Food and Drug Administration. Ketoconazole labeling revised
(1984)
Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
T. Bergan (1987)
10.1128/AAC.31.5.709
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function.
T. Gasser (1987)
Ciprofloxacin therapy in cystic fibrosis.
B. E. Scully (1987)
10.1093/JAC/26.SUPPL_B.51
Pharmacokinetics of quinolones in renal insufficiency.
J. P. Fillastre (1990)
10.1097/00132586-199502000-00014
Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.
K. Olkkola (1994)
10.1038/clpt.1994.60
Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole
K. Olkkola (1994)
10.1038/clpt.1994.184
Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole
A. Varhe (1994)
10.1096/fasebj.9.8.7768362
Expression and role of ionotropic glutamate receptors in pancreatic islet cells
N. Inagaki (1995)
Characteristics of intraconazole and ketoconazole inhibition of digoxin transport across renal tubular cells
S Ito (1995)
10.2165/00003495-199651060-00010
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
R. Davis (1996)
10.1177/106002809703100410
Digoxin–Itraconazole Interaction: Possible Mechanisms
Christopher P Alderman (1997)
Systemic antifungal agents: drug interactions of clinical significance
E Albengres (1998)
10.1002/(SICI)1099-081X(199904)20:3<145::AID-BDD167>3.0.CO;2-H
Effect of itraconazole on the pharmacokinetics of digoxin in guinea pigs
K. Nishihara (1999)
10.2165/00002018-200022060-00006
Fluoroquinolone-Induced Renal Failure
B. Lomaestro (2000)
10.1007/s002280000192
Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia
K. Raaska (2000)
Drug Facts and Comparisons Facts and Comparisons: St Louis
(2000)
10.1111/J.1365-2885.2005.00698.X
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
N. L. Regmi (2005)
10.1007/BF01062109
Statistical moments in pharmacokinetics
K. Yamaoka (2005)
372–373
Mayersohn M. Noncompartmental determination of the steady-st Perrier D (2007)
479–485
Lomaestro BM. Fluoroquinolone-induced renal failure. Drug Sa 2000 (2007)
Ltd. Biopharm. Drug Dispos
Ketoconazole (2007)
Ltd. Biopharm. Drug Dispos
H S Abou-Auda (2007)
Drug Facts and Comparisons . 2000 – 2001
S Ito
BDD



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar